TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 DKK)
| Closing information | 2023/03 | 2022/03 | 2021/03 |
| Turnover |
1,061,206
|
910,058
|
1,939,231 |
| Earnings before taxes |
20,852
|
42,721
|
913,721 |
| Total assets |
485,750
|
622,293
|
2,017,020 |
| Current assets |
410,236
|
556,571
|
1,951,086 |
| Current liabilities |
375,272
|
525,597
|
952,485 |
| Equity capital |
94,892
|
81,238
|
1,046,401 |
| - share capital |
10,100
|
10,100
|
10,100 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Solvency |
19.5%
|
13.1%
|
51.9% |
| Turnover per employee |
3,032
|
2,600
|
5,541 |
| Profit as a percentage of turnover |
2.0%
|
4.7%
|
47.1% |
| Return on assets (ROA) | |||
| Current ratio |
109.3%
|
105.9%
|
204.8% |
| Return on equity (ROE) |
22.0%
|
52.6%
|
87.3% |
| Change turnover |
151,148
|
-1,029,173
|
369,638 |
| Change turnover % |
17%
|
-53%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.